BG62332B1 - Съединение с формула 4-[/2-бензотиазолил/метиламино]-алфа-[/3,4-дифлуорофенокси/метил]-1-пиперидинетанол, методи занеговото получаване и използване, както и фармацевтични състави стова съединение и методи за получаването им - Google Patents

Съединение с формула 4-[/2-бензотиазолил/метиламино]-алфа-[/3,4-дифлуорофенокси/метил]-1-пиперидинетанол, методи занеговото получаване и използване, както и фармацевтични състави стова съединение и методи за получаването им Download PDF

Info

Publication number
BG62332B1
BG62332B1 BG98068A BG9806893A BG62332B1 BG 62332 B1 BG62332 B1 BG 62332B1 BG 98068 A BG98068 A BG 98068A BG 9806893 A BG9806893 A BG 9806893A BG 62332 B1 BG62332 B1 BG 62332B1
Authority
BG
Bulgaria
Prior art keywords
formula
compound
preparation
optionally
reaction
Prior art date
Application number
BG98068A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98068A (bg
Inventor
Raymond A. Stokbroekx
Gilbert A. Grauwels
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG98068A publication Critical patent/BG98068A/bg
Publication of BG62332B1 publication Critical patent/BG62332B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BG98068A 1991-02-25 1993-08-24 Съединение с формула 4-[/2-бензотиазолил/метиламино]-алфа-[/3,4-дифлуорофенокси/метил]-1-пиперидинетанол, методи занеговото получаване и използване, както и фармацевтични състави стова съединение и методи за получаването им BG62332B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
PCT/EP1992/000356 WO1992014731A1 (en) 1991-02-25 1992-02-14 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL

Publications (2)

Publication Number Publication Date
BG98068A BG98068A (bg) 1994-06-30
BG62332B1 true BG62332B1 (bg) 1999-08-31

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98068A BG62332B1 (bg) 1991-02-25 1993-08-24 Съединение с формула 4-[/2-бензотиазолил/метиламино]-алфа-[/3,4-дифлуорофенокси/метил]-1-пиперидинетанол, методи занеговото получаване и използване, както и фармацевтични състави стова съединение и методи за получаването им

Country Status (36)

Country Link
US (2) US5434168A (ko)
EP (2) EP0573473B1 (ko)
JP (1) JP2825652B2 (ko)
KR (1) KR0165901B1 (ko)
CN (3) CN1033454C (ko)
AT (1) ATE131478T1 (ko)
AU (1) AU649788B2 (ko)
BG (1) BG62332B1 (ko)
CA (1) CA2104000A1 (ko)
CY (1) CY1924A (ko)
CZ (1) CZ284705B6 (ko)
DE (1) DE69206787T2 (ko)
DK (1) DK0573473T3 (ko)
DZ (1) DZ1560A1 (ko)
EE (1) EE02983B1 (ko)
ES (1) ES2083737T3 (ko)
FI (1) FI933719A (ko)
GR (1) GR3018692T3 (ko)
HK (1) HK172296A (ko)
HU (2) HUT67695A (ko)
IE (1) IE69567B1 (ko)
IL (3) IL100952A (ko)
LV (1) LV11689B (ko)
MA (1) MA22447A1 (ko)
MX (1) MX9200777A (ko)
NO (1) NO300591B1 (ko)
NZ (2) NZ248437A (ko)
PL (1) PL168791B1 (ko)
RO (1) RO112959B1 (ko)
RU (2) RU2094434C1 (ko)
SK (1) SK278705B6 (ko)
TN (1) TNSN92017A1 (ko)
TW (1) TW218016B (ko)
WO (1) WO1992014731A1 (ko)
ZA (1) ZA921341B (ko)
ZW (1) ZW1992A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (ko) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
NZ295132A (en) * 1994-10-14 1998-06-26 Janssen Pharmaceutica Nv Sabeluzole aqueous suspension having ph from 8 to 10
EP0794777A1 (en) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzole intravenous solutions
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
IL123083A0 (en) * 1995-10-25 1998-09-24 Janssen Pharmaceutica Nv Lubeluzole n-oxides their preparation and pharmaceutical compositions containing them
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
MA22447A1 (fr) 1992-10-01
LV11689A (lv) 1997-02-20
RU2094434C1 (ru) 1997-10-27
JP2825652B2 (ja) 1998-11-18
ZA921341B (en) 1993-08-24
US5434168A (en) 1995-07-18
EE02983B1 (et) 1997-04-15
RO112959B1 (ro) 1998-02-27
CN1033454C (zh) 1996-12-04
SK278705B6 (sk) 1998-01-14
PL168791B1 (pl) 1996-04-30
IL100952A0 (en) 1992-11-15
EP0501552A1 (en) 1992-09-02
HUT67695A (en) 1995-04-28
RU95112519A (ru) 1997-04-20
ATE131478T1 (de) 1995-12-15
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
BG98068A (bg) 1994-06-30
CN1043609C (zh) 1999-06-16
NZ241592A (en) 1994-07-26
CA2104000A1 (en) 1992-08-26
HU211560A9 (en) 1995-12-28
DZ1560A1 (fr) 2002-02-17
IE69567B1 (en) 1996-10-02
AU1208592A (en) 1992-09-15
NO933010D0 (no) 1993-08-24
IL113837A (en) 1996-05-14
FI933719A0 (fi) 1993-08-24
DE69206787D1 (de) 1996-01-25
IE920575A1 (en) 1992-08-26
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
NO300591B1 (no) 1997-06-23
IL113837A0 (en) 1995-08-31
TW218016B (ko) 1993-12-21
MX9200777A (es) 1992-08-01
ZW1992A1 (en) 1993-09-22
CN1064865A (zh) 1992-09-30
CN1113437A (zh) 1995-12-20
RU2106348C1 (ru) 1998-03-10
KR0165901B1 (en) 1999-01-15
EP0573473B1 (en) 1995-12-13
LV11689B (en) 1997-08-20
CS51292A3 (en) 1992-09-16
GR3018692T3 (en) 1996-04-30
JPH06505012A (ja) 1994-06-09
CY1924A (en) 1997-03-07
FI933719A (fi) 1993-08-24
CN1117048A (zh) 1996-02-21
US5675027A (en) 1997-10-07
WO1992014731A1 (en) 1992-09-03
NZ248437A (en) 1994-07-26
NO933010L (no) 1993-08-24
DK0573473T3 (da) 1996-01-29
CZ284705B6 (cs) 1999-02-17
HU9302395D0 (en) 1993-11-29
TNSN92017A1 (fr) 1993-06-08
AU649788B2 (en) 1994-06-02
ES2083737T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
DE60129210T2 (de) Zyklische amid-derivate
WO1999032481A1 (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
PL188908B1 (pl) Nowe pochodne benzimidazolu i ich zastosowanie dowytwarzania leków do leczenia stanów alergicznych
BG62332B1 (bg) Съединение с формула 4-[/2-бензотиазолил/метиламино]-алфа-[/3,4-дифлуорофенокси/метил]-1-пиперидинетанол, методи занеговото получаване и използване, както и фармацевтични състави стова съединение и методи за получаването им
US20110160199A1 (en) Aralkyl Substituted Piperidine or Piperazine Derivatives and Their Use for Treating Schizophrenia
JPH10203986A (ja) 眼疾患用薬剤
AU688186B2 (en) (Thiophen-2-YL)-piperidin or tetrahydropyridin carboxamides
WO1999032486A1 (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
CN1125065C (zh) 苯并[g]喹啉衍生物
US5972925A (en) Heterocyclic compounds
EP0329932B1 (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
JPH05506440A (ja) アルコキシ置換ジヒドロベンゾピラン―2―カルボン酸およびその誘導体
EP0869954B1 (en) Heterocyclic compounds for use in the treatment of neurogenic inflammation
JPH11512090A (ja) 1−(ヘテロ)アリール−4−(縮合チアゾール−2−イルアルキル)−ピペラジン誘導体、その製造方法及び5−ht▲下1a▼受容体介在疾患の治療におけるその使用
US5530011A (en) 4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
JP3092827B2 (ja) アルケンアミド誘導体及びそのアルケンアミド誘導体を用いた抗アレルギー剤、アルケン酸、そのアルケン酸の製造方法
WO1999032443A1 (en) Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions
JPH0641079A (ja) ピリジン誘導体
WO1999032445A1 (en) Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists
JPH06211787A (ja) N−フェネチルアゼピン誘導体およびその用途
JP2002515913A (ja) 新規ヘテロ環式化合物